Last reviewed · How we verify
Single-Compound Cannabidiol
At a glance
| Generic name | Single-Compound Cannabidiol |
|---|---|
| Sponsor | Staci Gruber, Ph.D. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Sublingual Cannabidiol for Anxiety (PHASE2)
- Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease (PHASE2)
- CBD for Dental Pain (PHASE1, PHASE2)
- Anesthetic Premedication With a Cannabis Extract (Cannapremed) (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |